190 related articles for article (PubMed ID: 9402532)
1. Detection of plasma (1 --> 3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias.
Yoshida M; Obayashi T; Iwama A; Ito M; Tsunoda S; Suzuki T; Muroi K; Ohta M; Sakamoto S; Miura Y
J Med Vet Mycol; 1997; 35(5):371-4. PubMed ID: 9402532
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections.
Mori T; Ikemoto H; Matsumura M; Yoshida M; Inada K; Endo S; Ito A; Watanabe S; Yamaguchi H; Mitsuya M; Kodama M; Tani T; Yokota T; Kobayashi T; Kambayashi J; Nakamura T; Masaoka T; Teshima H; Yoshinaga T; Kohno S; Hara K; Miyazaki S
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):553-60. PubMed ID: 9263735
[TBL] [Abstract][Full Text] [Related]
3. [Plasma (1-->3)-beta-D-glucan determination for screening deep mycosis].
Obayashi T
Rinsho Byori; 1996 Jun; 44(6):528-32. PubMed ID: 8752730
[TBL] [Abstract][Full Text] [Related]
4. Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
Nomura S; Iishii K; Inami N; Kimura E; Urase F
Pathophysiol Haemost Thromb; 2007; 36(1):32-9. PubMed ID: 18332612
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of (1-3)-beta-D-glucan in aspergillosis and cryptococcosis].
Mitsutake K; Miyazaki T; Miyazaki H; Iwamoto M; Maesaki S; Hashimoto A; Kaku M; Koga H; Kohno S; Hara K
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):37-41. PubMed ID: 8114372
[TBL] [Abstract][Full Text] [Related]
6. [The usefulness of fluconazole administration and beta-D-glucan measurement in neurosurgical patients with deep-seated mycosis].
Kusanagi H; Shimura T; Teramoto A
No Shinkei Geka; 2000 Aug; 28(8):685-90. PubMed ID: 11002490
[TBL] [Abstract][Full Text] [Related]
7. Perchloric acid, toxicolor, endospecy, and miconazole in the early diagnosis and treatment of fungemia.
Endo S; Inoue Y; Amano K; Yamada A; Fujii N; Nakamura A; Nagasawa T; Kikuchi M; Taki K; Hoshi S
Clin Ther; 1990; 12(1):48-53. PubMed ID: 2158403
[TBL] [Abstract][Full Text] [Related]
8. Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes.
Obayashi T; Yoshida M; Mori T; Goto H; Yasuoka A; Iwasaki H; Teshima H; Kohno S; Horiuchi A; Ito A
Lancet; 1995 Jan; 345(8941):17-20. PubMed ID: 7799700
[TBL] [Abstract][Full Text] [Related]
9. Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?
Nakase K; Suzuki K; Kyo T; Kohara T; Sugawara Y; Katayama N
Int J Infect Dis; 2012 Jan; 16(1):e2-e4. PubMed ID: 22071235
[TBL] [Abstract][Full Text] [Related]
10. Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis.
Miyazaki T; Kohno S; Mitsutake K; Maesaki S; Tanaka K; Ishikawa N; Hara K
J Clin Microbiol; 1995 Dec; 33(12):3115-8. PubMed ID: 8586684
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of serum β-d-glucan levels in 78 patients with Trichosporon fungemia.
Kushima H; Ishii H; Komiya K; Tokimatsu I; Kadota J
Int J Infect Dis; 2013 Feb; 17(2):e134-5. PubMed ID: 22832213
[No Abstract] [Full Text] [Related]
12. Fungal infections in iatrogenically compromised hosts.
Rex JH; Walsh TJ; Anaissie EJ
Adv Intern Med; 1998; 43():321-71. PubMed ID: 9506187
[No Abstract] [Full Text] [Related]
13. Diagnosis of invasive fungal infections: advances in nonculture systems.
Walsh TJ; Chanock SJ
Curr Clin Top Infect Dis; 1998; 18():101-53. PubMed ID: 9779353
[No Abstract] [Full Text] [Related]
14. Fatal Trichosporon fungemia in patients with hematologic malignancies.
Suzuki K; Nakase K; Kyo T; Kohara T; Sugawara Y; Shibazaki T; Oka K; Tsukada T; Katayama N
Eur J Haematol; 2010 May; 84(5):441-7. PubMed ID: 20059528
[TBL] [Abstract][Full Text] [Related]
15. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections.
Metan G; Koc AN; Ağkuş Ç; Kaynar LG; Alp E; Eser B
Rev Iberoam Micol; 2012; 29(3):169-71. PubMed ID: 21907303
[TBL] [Abstract][Full Text] [Related]
16. Invasive infection due to Trichosporon cutaneum in patients with hematologic malignancies.
Kataoka-Nishimura S; Akiyama H; Saku K; Kashiwa M; Mori S; Tanikawa S; Sakamaki H; Onozawa Y
Cancer; 1998 Feb; 82(3):484-7. PubMed ID: 9452265
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of fungal infection: new technologies for the mycology laboratory.
Alexander BD
Transpl Infect Dis; 2002; 4 Suppl 3():32-7. PubMed ID: 12486790
[TBL] [Abstract][Full Text] [Related]
18. Trichosporon cutaneum fungemia in patients with acute myeloblastic leukemia and measurement of serum D-arabinitol, Candida antigen (CAND-TEC), and beta-D-glucan.
Morimoto S; Shimazaki C; Goto H; Hirata Y; Tasumi T; Yamagata N; Hirata T; Ashihara E; Inaba T; Fujita N
Ann Hematol; 1994 Mar; 68(3):159-61. PubMed ID: 8167183
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
20. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis.
Kami M; Fukui T; Ogawa S; Kazuyama Y; Machida U; Tanaka Y; Kanda Y; Kashima T; Yamazaki Y; Hamaki T; Mori S; Akiyama H; Mutou Y; Sakamaki H; Osumi K; Kimura S; Hirai H
Clin Infect Dis; 2001 Nov; 33(9):1504-12. PubMed ID: 11588697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
